Literature DB >> 2073786

The role of viruses and environmental factors in the induction of diabetes.

J W Yoon1.   

Abstract

The development of IDDM results from the destruction of pancreatic beta cells. Genetic factors, various immune system alterations, and environmental factors have been studied as the possible causes of IDDM. The concordance rate for developing IDDM between monozygotic twins approaches 50%, suggesting that genetic factors are necessary, but nongenetic factors such as various immune system alterations and environmental factors also influence the clinical expression of genetic susceptibility. Environmental factors (e.g., viruses, chemicals, and diet) affecting the induction of diabetes may act as primary injurious agents which damage pancreatic beta cells or as triggering agents of autoimmunity. Certain viruses including EMC-D and Mengo virus 2T can directly infect pancreatic beta cells and replicate in the cells. The replication of viruses in the beta cells results in the destruction of the cells within 3 days, and the infected mice develop a diabeteslike syndrome in 3-4 days without the involvement of autoimmunity. In contrast, rubella virus appears to be somewhat weakly associated with autoimmune IDDM in hamsters. In addition, endogenous retrovirus expressed in pancreatic beta cells is clearly associated with the development of insulitis and diabetes in NOD mice. In man, there appears to be no correlation between the detection of islet cell autoantibodies and anti-Coxsackie B viral antibodies in newly diagnosed IDDM. In contrast, persistent infection of CMV and rubella virus appears to be associated with the presence of autoantibodies in newly diagnosed IDDM patients. It is particularly noteworthy that human CMV can induce islet cell autoantibodies that react specifically with a 38 kDa islet cell protein which may represent islet cell-specific antigens in a proportion of CMV-associated IDDM cases. These observations suggest that the association of diabetes with Coxsackie B viruses might be due to cytolytic infection of the beta cells with no link to autoimmunity, while both rubella virus and CMV are probably associated with autoimmune IDDM. A number of structurally diverse chemicals including alloxan, streptozotocin, chlorozotocin, Vacor, and cyproheptadine are diabetogenic mainly in rodents and sometimes in man. Possible mechanisms for beta cell destruction by these chemicals include (a) generation of oxygen free radicals and alteration of endogenous scavengers of these reactive species; (b) breakage of DNA and a consequent increase in the activity of poly-ADP-ribose synthetase, an enzyme depleting nicotinamide adenine dinucleotide in beta cells; and (c) inhibition of active calcium transport and calmodulin-activated protein kinase activity. (ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073786     DOI: 10.1007/978-3-642-75741-9_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  31 in total

1.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

2.  A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.

Authors:  Urs Christen; Kurt H Edelmann; Dorian B McGavern; Tom Wolfe; Bryan Coon; Meghann K Teague; Stephen D Miller; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Viruses contribute to the development of Sjögren's syndrome.

Authors:  P Youinou; J-O Pers; A Saraux; Y-L Pennec
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.

Authors:  A L Scarim; M Arnush; L A Blair; J Concepcion; M R Heitmeier; D Scheuner; R J Kaufman; J Ryerse; R M Buller; J A Corbett
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.

Authors:  Wassim Chehadeh; Pierre-Emmanuel Lobert; Pierre Sauter; Anne Goffard; Bernadette Lucas; Jacques Weill; Marie-Christine Vantyghem; Gunnar Alm; Pascal Pigny; Didier Hober
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  The environment and the origins of islet autoimmunity and Type 1 diabetes.

Authors:  S Eringsmark Regnéll; A Lernmark
Journal:  Diabet Med       Date:  2013-02       Impact factor: 4.359

8.  Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.

Authors:  A Hänninen; S Jalkanen; M Salmi; S Toikkanen; G Nikolakaros; O Simell
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells.

Authors:  P Ylipaasto; K Klingel; A M Lindberg; T Otonkoski; R Kandolf; T Hovi; M Roivainen
Journal:  Diabetologia       Date:  2004-01-15       Impact factor: 10.122

10.  Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children.

Authors:  Anna-Lena Nilsson; Fariba Vaziri-Sani; Cecilia Andersson; Karin Larsson; Anneli Carlsson; Elisabeth Cedervall; Björn Jönsson; Jan Neiderud; Helena Elding Larsson; Sten-Anders Ivarsson; Åke Lernmark
Journal:  Viral Immunol       Date:  2013-05-17       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.